HOUSTON - Taking the most commonly-prescribed anti-diabetic drug, metformin, reduces an individual's risk of developing pancreatic cancer by 62 percent, according to research from The University of Texas M. D. Anderson Cancer Center, published in the Aug. 1 issue of Gastroenterology.

read more>>

Every year, 42,000 Americans are diagnosed with pancreatic cancer. Few live very long, and less than 5% are still alive five years after diagnosis.There's new hope, though, from the lab of Prof. Yoel Kloog, dean of Tel Aviv University's Faculty of Life Sciences. His drug compound Salirasib has shown positive results against pancreatic cancer and recently passed Phase I/II clinical trials. The…

read more>>

Prognosis of pancreatic cancer is poor. Recently, it has been clarified that the grade of tumor angiogenesis is a useful prognostic marker in human cancer, including pancreatic cancer. To establish the grade of tumor angiogenesis by non-invasive imaging may be important clinically. However, there are only a few such reports on pancreatic cancer.

read more>>

Brookline -- The Howard Hughes Medical Institute has awarded a Physician-Scientist Early Career Grant to Brookline resident Dr. Brian Wolpin, a clinician-researcher at Dana Farber Cancer Institute in Boston, who is searching for genes and environmental factors that predispose people to pancreatic cancer.

read more>>

A new Northwestern University-led study of human colon, pancreatic and lung cells is the first to report that cancer cells and their non-cancerous cell neighbors, although quite different under the microscope, share very similar structural abnormalities on the nanoscale level.The findings, obtained using an optical technique that can detect features as small as 20 nanometers, validate the "…

read more>>

EXTON, Penn. -- Morphotek(R), Inc., a subsidiary of Eisai Corporation of North America, announced a research collaboration agreement with Synageva BioPharma Corporation to express and develop therapeutic monoclonal antibodies for the potential treatment of various forms of cancer and infectious disease.

read more>>

BETHPAGE, N.Y. -- The Lustgarten Foundation, the nation's largest private supporter of pancreatic cancer research, today announced its first round of 2009 grants, totaling $1.6 million awarded to six leading research centers for early diagnostic tests and better treatment for one of the nation's deadliest cancers.

read more>>

HOUSTON - In reviewing the weight history of pancreatic cancer patients across their life spans, researchers at The University of Texas M. D. Anderson Cancer Center have determined that a high body mass index in early adulthood may play a significant role in an individual developing the disease at an earlier age.The study, published in the June 24 issue of the Journal of the American Medical…

read more>>

CARLSBAD, Calif. --The University of Queensland’s Institute for Molecular Bioscience (IMB) and Life Technologies Corporation (NASDAQ:LIFE), today announced a strategic scientific research collaboration to study pancreatic and ovarian cancer in Australia.

read more>>

PHILADELPHIA - Smoking has once again been implicated in the development of advanced cancer. Exposure to nicotine by way of cigarette smoking may increase the likelihood that pancreatic ductal adenocarcinoma will become metastatic, according to researchers from the Kimmel Cancer Center at Jefferson. Their study was published in the August edition of the journal Surgery.

read more>>